Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: GENOVAC ANTIBODY DISCOVERY LLC
Awarding agency: Department of Defense / Defense Health Agency
Funding agency: Department of Defense / Defense Health Agency
Period of performance: 2024-09-06 to 2025-06-27
Current total value of award: $120000
Description: HUMAN MONOCLONAL ANTIBODY DEVELOPMENT